The Current Ratio as of September 2024 (TTM) for Bausch + Lomb Corporation (BLCO) is 1.65

According to Bausch + Lomb Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 1.65. This represents a change of -3.70% compared to the average of 1.72 of the last 4 quarters.

Bausch + Lomb Corporation (BLCO) Historical Current Ratio (quarterly & annually)

How has BLCO Current Ratio performed in the past?

The mean historical Current Ratio of Bausch + Lomb Corporation over the last ten years is 1.39. The current 1.65 Current Ratio has changed 11.80% with respect to the historical average. Over the past ten years (40 quarters), BLCO's Current Ratio was at its highest in in the December 2020 quarter at 1.82. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Bausch + Lomb Corporation (BLCO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Bausch + Lomb Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bausch + Lomb Corporation (BLCO) Average Current Ratio

How has BLCO Current Ratio performed in the past?

The current Current Ratio of Bausch + Lomb Corporation (BLCO) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Bausch + Lomb Corporation (BLCO) Current Ratio vs. Peers

How is BLCO’s Current Ratio compared to its peers?

Bausch + Lomb Corporation’s Current Ratio is less than The Cooper Companies, Inc. (1.99), less than ICU Medical, Inc. (2.40), less than Hologic, Inc. (3.99), less than Becton, Dickinson and Company (1.85), less than Teleflex Incorporated (2.58), less than West Pharmaceutical Services, Inc. (2.34), less than Alcon Inc. (2.56), less than ResMed Inc. (2.59), less than Akoya Biosciences, Inc. (2.73), less than AtriCure, Inc. (4.13), less than Atrion Corporation (6.80), less than Haemonetics Corporation (3.76), less than AngioDynamics, Inc. (2.12), greater than AptarGroup, Inc. (1.36),

Build a custom stock screener for Bausch + Lomb Corporation (BLCO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bausch + Lomb Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bausch + Lomb Corporation (BLCO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bausch + Lomb Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.